Qiong H. Du

32 Renmin South Road
Shiyan, 442000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 71 publications

Analysis of the prevalence characteristics and trends of allergen-specific IgE levels in a children's hospital in Wuhan City from 2019 to 2024

Analysis of the prevalence characteristics and trends of allergen-specific IgE levels in a children's hospital in Wuhan City from 2019 to 2024

Journal: Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]

Published: June 22, 2026

Unveiling the hidden risks of nanomedicine-based drug delivery: a comparative evaluation of drug safety profiles of liposomal irinotecan and conventional irinotecan.

Unveiling the hidden risks of nanomedicine-based drug delivery: a comparative evaluation of drug safety profiles of liposomal irinotecan and conventional irinotecan.

Journal: Nanotoxicology

Published: February 17, 2026

Exploring the optimal regimen in advanced hepatocellular carcinoma: a protocol of individual patient data network meta-analysis of randomized controlled trials.

Exploring the optimal regimen in advanced hepatocellular carcinoma: a protocol of individual patient data network meta-analysis of randomized controlled trials.

Journal: Frontiers in immunology

Published: February 05, 2026

Comparative efficacy and safety of four long-acting granulocyte colony-stimulating factors for primary prophylaxis in patients with breast cancer: a prospective observational cohort study in China.

Comparative efficacy and safety of four long-acting granulocyte colony-stimulating factors for primary prophylaxis in patients with breast cancer: a prospective observational cohort study in China.

Journal: EClinicalMedicine

Published: January 25, 2026

Cost-effectiveness analysis of anlotinib plus penpulimab versus sorafenib in the treatment of unresectable hepatocellular carcinoma.

Cost-effectiveness analysis of anlotinib plus penpulimab versus sorafenib in the treatment of unresectable hepatocellular carcinoma.

Journal: Human vaccines & immunotherapeutics

Published: December 01, 2025

Pharmacovigilance insights into drug-induced hypercalcemia: evidence from the U.S. FDA Adverse Event Reporting System (FAERS) database.

Pharmacovigilance insights into drug-induced hypercalcemia: evidence from the U.S. FDA Adverse Event Reporting System (FAERS) database.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: November 26, 2025

Genomic Alterations and Their Clinical Implications in Pancreatic Ductal Adenocarcinoma in a Large-Scale Chinese Cohort.

Genomic Alterations and Their Clinical Implications in Pancreatic Ductal Adenocarcinoma in a Large-Scale Chinese Cohort.

Journal: Cancer medicine

Published: November 14, 2025

Distinct safety profiles of liposomal and conventional irinotecan: insights from clinical experience and real-world data.

Distinct safety profiles of liposomal and conventional irinotecan: insights from clinical experience and real-world data.

Journal: Frontiers in pharmacology

Published: November 13, 2025

Machine learning-based predictive model for severe pneumonia in children

Machine learning-based predictive model for severe pneumonia in children

Journal: Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]

Published: October 23, 2025

Unveiling the hidden cardiovascular risk of sipuleucel-T: a pharmacovigilance analysis using the FDA Adverse Event Reporting System, 2010-2025.

Unveiling the hidden cardiovascular risk of sipuleucel-T: a pharmacovigilance analysis using the FDA Adverse Event Reporting System, 2010-2025.

Journal: Frontiers in immunology

Published: September 30, 2025

Nivolumab plus ipilimumab versus lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma: A cost-effectiveness analysis.

Nivolumab plus ipilimumab versus lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma: A cost-effectiveness analysis.

Journal: Cancer

Published: September 29, 2025

Mapping cell type-resolved transcriptomic profiles to patient survival in pancreatic cancer.

Mapping cell type-resolved transcriptomic profiles to patient survival in pancreatic cancer.

Journal: Cancer cell

Published: September 16, 2025

Showing 1-12 of 71

Last Updated: 09/26/2026